Tackling Cardiotoxicity During Drug Development
Did you know that the adverse effect of drugs on cardiac tissue – known as cardiotoxicity – is one of the principal reasons that therapeutics are withdrawn from the market?
To minimize and manage this risk, researchers use predictive assays early on in the drug development process.
Download this infographic to learn more about:
- The effects of drug-induced cardiotoxicity
- New in vitro strategies to assess cardiotoxicity
- The importance of combining assays for viability, contractility, electrophysiology and metabolism